HI
COLL icon

HBK Investments’s Collegium Pharmaceutical COLL Stock Holding History

HBK Investments’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-68,800
Closed -$1.04M – 691
2019
Q1 		$1.04M Buy
68,800
+31,349
+84% +$502K 0.01% 665
2018
Q4 		$643K Buy
+37,451
New +$641K 0.01% 823

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

HBK Investments's COLL Position: Q2 2019 in Review

HBK Investments sold out of Collegium Pharmaceutical (COLL) in Q2 2019, closing a stake of 68,800 shares — an estimated $1.04M sold.

HBK Investments first reported a position in COLL in Q4 2018 and held it in 2 quarters. The position peaked at $1.04M in Q1 2019. 128 funds tracked by Wall St. Rank hold COLL as of Q2 2019.

  • HBK Investments reported no remaining Collegium Pharmaceutical position as of Q2 2019 after selling out during the quarter.
  • HBK Investments sold 68,800 Collegium Pharmaceutical shares in Q2 2019, an estimated $1.04M.
  • HBK Investments first reported a position in Collegium Pharmaceutical in Q4 2018 and held it in 2 quarters.
  • HBK Investments's Collegium Pharmaceutical position peaked at $1.04M in Q1 2019.
  • 128 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2019.

Based on HBK Investments's 13F filing for Q2 2019, filed 14 Aug 2019.